Comments
Loading...

Century Therapeutics

IPSCNASDAQ
Logo brought to you by Benzinga Data
$0.8207
-0.03-3.45%
At close: -
$0.8207
0.000.00%
After Hours: Jan 31, 4:02 PM EDT

Century Therapeutics (NASDAQ:IPSC) Stock, Earnings Estimates, EPS, And Revenue

Century Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 13
EPS Estimate
$-0.440
Quarterly Revenue Estimate
$975.00K
Annual Revenue
(as of Sep 30)
$2.68M

Analyze the earnings history of Century Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Century Therapeutics (IPSC) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-05$-0.37$-0.4517.8 %
Q22024-08-08$-0.38$-0.4617.4 %
Q12024-05-09$-0.45$-0.5010.0 %
Q42024-03-14$-0.65$-0.55-18.2 %

Century Therapeutics (IPSC) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-05$791.00K$2.02M-60.8 %
Q12024-05-09$855.00K$1.26M-32.1 %
Q42024-03-14$268.00K$1.84M-85.4 %
Q32023-11-09$148.00K$1.16M-87.2 %

FAQ

Q

When is Century Therapeutics (NASDAQ:IPSC) reporting earnings?

A

Century Therapeutics (IPSC) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Century Therapeutics (NASDAQ:IPSC)?

A

The Actual EPS was $-0.37, which beat the estimate of $-0.45.

Q

What were Century Therapeutics’s (NASDAQ:IPSC) revenues?

A

The Actual Revenue was $791K, which missed the estimate of $2M.

Browse earnings estimates, EPS, and revenue on all stocks.